Читаем без скачивания Антирак груди - Джейн Плант
Шрифт:
Интервал:
Закладка:
255
www.nlm.nih.gov/medlineplus/ency/article/002919.htm
256
McKenna, Claire, 2002. UK has highest reduction in deaths from lung and breast cancer. BMJ, 325, 63.
257
Irwig, Les, 2006. Evaluating new screening tests for breast cancer. BMJ, 332, 678–679.
258
Anon, 2006. Screening for breast cancer. BMJ, 332, 499–500.
259
www.nlm.nih.gov/medineplus/ency/article/002919.htm
260
e. g. Baum, M., 2000. Survival and reduction in mortality from breast cancer – Impact of mammographic screening is hot clear (Letter). BMJ, 321, 1470.
261
Spurgeon, David, 2002. Annual mammography in women in their 40s does not cut death rate. BMJ, 325, 563.
262
Spurgeon, David, 2002. Annual mammography in women in their 40s does not cut death rate. BMJ, 325, 563.
263
Josefson, Deborah, 2002. Breast self-examination does not improve cancer survival. BMJ, 325, 793.
264
Zackrisson S. and others, 2006. Rare of over-diagnosis of breast cancer 15 years after end of Malmo mammographic screening trial; follow up study. BMJ, 332, 689–692.
265
Anon, 2006. Screening for breast cancer. BMJ, 332, 499–500.
266
Symonds, R. Paul, 2002. Cancer biology may be more important than diagnostic delay. BMJ, 325, 774.
267
Spurgeon, David, 2002. Annual mammography in women in their 40s does not cut death rate. BMJ, 325, 563.
268
www.cancerscreening.nhs.uk/breastscreen
269
White, Caroline, 2002. 'Unacceptable' errors found in breast screening process. BMJ, 324, 933.
270
UK National Radiological Protection Board, www.nrpb.org/radiation_topics/risks/exposure.htm
271
Irwig, Les, 2006. Evaluating new screening tests for breast cancer. BMJ, 332, 678–679.
272
Гистерэктомия (hysterectomy) – хирургическое удаление матки. – Примеч. ред.
273
www.well-connected.com/rreports/doc06full.html
274
www.well-connected.con'i/rreports/doc06full.html
275
Keyomarsi, K., Tucker, S. L., Buchholz, T. A., Callister, M., Ding, Y., Hortobagyi, G. N., Bedrosian, I. Knickerbocker, C., Toyofuku, W., Lowe, M., Herliczek, T. W., and Bacus, S. S., 2002. Cyclin E and Survival in Patients with Breast Cancer. N. Engl. J. Med., 347, 1566–1575.
276
Yancik, R. and Ries, L. A., 1994. Cancer in older persons. Magnitude of the problem – how do we apply what we know? Cancer, 74 (7 Suppl), 1995–2003.
277
Silliman, R. A. and Baeke, P., 1998. Breast cancer in the older woman. In: Balducci, L., Ersher, W. B. and Lyman, G. H., Comprehensive geriatric oncology. Amsterdam: Harwood.
278
Welch, H. G., Albertson, F. C., Nease, R. F., Bubolz, T. A. and Wasson, J. H., 1996. Estimating treatment benefits for the elderly: the effect of competing risks. Ann Intern Med, 124, 577–584.
279
Holmes, F. F., 1994. Clinical course of cancer in the elderly. Cancer Control, 1, 108–114.
280
Nixon, A. J., Neuberg, D., Hayes, D. F., Gelman, R., Connolly, J. L., Schnitt, S. and others, 1994. Relationship of patient age to pathological features of the tumor and prognosis for patients with stage I or II breast cancer. J. Clin. Oncol., 12, 888–894.
281
Balducci, Lodovico and Phillips, D. Melissa. 1998. Breast cancer in older women. American Family Physician. October 1, 1998. www.aafp.org/afp/981001ap/balducci.html
282
www.well-connected.com/rreports/doc06full.html
283
Medical Report: Prostate Cancer. ICON, 2002, 1 (5), 8–10.
284
Waxman, Jonathan, 2001. The Prostate Cancer Book. London: Vermillion.
285
http://www.nccn.org/paticnt_gls/_english/_prostate/
286
http://www.nccn.org/patient_gls/_english/_prostate/
287
Hart, D. and Wall, 2004. UK population dose from medical examinations. European Journal of Radiology, 50 (3), 285–291, Brenner, D. I. and others, 2001. CT scanning of children has been calculated 10 increase their lifetime risk of cancer. American Journal of Roentology, 176, 289–296.
288
http://www.nccn.org/patient_gls/_english/_prostate/
289
http://www.cancer.org
290
Spurgeon, David, 2003. Advanced scanning techniques help doctors stage prostate cancer. BMJ, 326, 1418.
291
New England Journal of Medicine, 2003, 348, 2491–2499.
292
http://www.nccn.org/patient_gls/_english/_prostate/
293
Fisher, B. and others, 2002. Twenty year follow-up of a randomised trial comparing total mastectomy, lumpectomy and lumpectomy plus irradiation for the treatment of invasive breast cancer. New England Journal of Medicine, 347 (16), 1233–1241.
294
Fisher, B., Bryant, J., Dignam, J. J., Wickerham, D. L., Mamounas, E. F., Fisher, E. R., Margolese, KG., Nesbitt, L., Paik, S., Pisansky, T. M., Wolmark, N., 2002. Tamoxifen, radiation therapy, or both for prevention of ipsilateral breast tumor recurrence after lumpectomy in women with invasive breast cancers of one centimeter or less. J. Clin. Oncol., 20 (20), 4141–4149; www.ncbi.nlm.nih.gov;80
295
Fisher, B., Anderson, S., Bryant, J., Margolese, R. G., Deutsch, M., Fisher, E. R., Jeong, J. H. and Wolmark, N., 2002. Twenty-year follow-up of a randomised trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N. Engl. J. Med., 347 (16), 1233–1241; www.ncbi.nlm.nih.gov;80
296
Gottlieb, Scott. Lumpectomy is as effective as mastectomy for breast cancer. BMJ, 325, 921.
297
www.nlm.nih.gov/medlineplus/ency/article/002919.htm
298
www.nlm.nih.gov/medlineplus/ency/article/002919.htm
299
www.cancer.org/docroot/cri/content/cri_2_6x_breast_reconstruction_after_mastectomy_5.asp
300
Bartelinkh and others, 2001. Recurrence rates after treatment of breast cancer with standard radiotherapy with or without additional radiation. New England J. Med., 345 (19), 1378–1387.
301
http://cis.nci.nih.gov/fact/7_16.htm
302
Morrow, Monica and Gradishar, William, 2002. Recent Development: Breast Cancer. BMJ, 324, 410–414.
303
Coombes, R. C. and others, 2006. American Society of Clinical Oncology, Annual Meeting, Atlanta Georgia, June 2006.
304
Gralow, Julie R., 2002. Bisphosphonates as adjuvant treatment for breast cancer. BMJ, 325, 1051–1052.
305
www.gene.com/gene/products/information/oncology/herceptin; www.herceptin.com/herceptin/physician/pi.htm
306
www.herceptin.com/herceptin/physician/pi.htm
307
Anon, 2006. Patient is to appeal High Court ruling on breast cancer drug. BMJ, 332–443.
308
Barrett, A. and others, 2006. How much will herceptin really cost? BMJ, 333, 1118–1120.
309
Daily Mail, Monday, 9 October, 2006.
310
www.ahrq.gov/news/press/pr2002/brchempr.htm
311
(adsbygoogle = window.adsbygoogle || []).push({});